Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1972 Jul 22;3(5820):205–207. doi: 10.1136/bmj.3.5820.205

Vitamin D Intoxication Treated with Porcine Calcitonin

R M Buckle, T R Gamlen, I M Pullen
PMCID: PMC1785685  PMID: 4261142

Abstract

Porcine calcitonin was used to treat three patients with hypercalcaemia due to vitamin D intoxication. In two patients a rapid and sustained fall to normal in serum calcium occurred within three days, in the third patient normocalcaemia was achieved in seven days. In view of its rapid and sustained effect calcitonin may be of value in the urgent treatment of hypercalcaemia due to vitamin D intoxication.

Full text

PDF
205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBRIGHT F., CARROLL E. L., DEMPSEY E. F., HENNEMAN P. H. The cause of hypercalcuria in sarcoid and its treatment with cortisone and sodium phytate. J Clin Invest. 1956 Nov;35(11):1229–1242. doi: 10.1172/JCI103378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ANDERSON J., HARPER C., DENT C. E., PHILPOT G. R. Effect of cortisone on calcium metabolism in sarcoidosis with hypercalcaemia; possibly antagonistic actions of cortisone and vitamin D. Lancet. 1954 Oct 9;267(6841):720–724. doi: 10.1016/s0140-6736(54)90492-4. [DOI] [PubMed] [Google Scholar]
  3. Bijvoet O. L., van der Sluys Veer J., Jansen A. P. Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia. Lancet. 1968 Apr 27;1(7548):876–881. doi: 10.1016/s0140-6736(68)90236-5. [DOI] [PubMed] [Google Scholar]
  4. DENT C. E., FLYNN F. V., NABARRO J. D. Hypercalcaemia and impairment of renal function in generalized sarcoidosis. Br Med J. 1953 Oct 10;2(4840):808–810. doi: 10.1136/bmj.2.4840.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FOREMAN H., FINNEGAN C., LUSHBAUGH C. C. Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy. J Am Med Assoc. 1956 Mar 24;160(12):1042–1046. doi: 10.1001/jama.1956.02960470038010. [DOI] [PubMed] [Google Scholar]
  6. Foster G. V., Joplin G. F., MacIntyre I., Melvin K. E., Slack E. Effect of thyrocalcitonin in man. Lancet. 1966 Jan 15;1(7429):107–109. doi: 10.1016/s0140-6736(66)91255-4. [DOI] [PubMed] [Google Scholar]
  7. Milhaud G., Moukhtar M. S., Bourichon J., Perault A. M. Existence et activité de la thyrocalcitonine chez l'homme. C R Acad Sci Hebd Seances Acad Sci D. 1965 Nov 22;261(21):4513–4516. [PubMed] [Google Scholar]
  8. Pak C. Y., Wills M. R., Smith G. W., 2nd, Bartter F. C. Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab. 1968 Nov;28(11):1657–1660. doi: 10.1210/jcem-28-11-1657. [DOI] [PubMed] [Google Scholar]
  9. VERNER J. V., Jr, ENGEL F. L., McPHERSON H. T. Vitamin D intoxication: report of two cases treated with cortisone. Ann Intern Med. 1958 Apr;48(4):765–773. doi: 10.7326/0003-4819-48-4-765. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES